Disease networks. Uncovering disease-disease relationships through the incomplete interactome.
Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barabási AL.
Science. 2015 Feb 20;347(6224):1257601. doi: 10.1126/science.1257601.
Human Organoids: Tools for Understanding Biology and Treating Diseases.
Schutgens F, Clevers H.
Annu Rev Pathol. 2020 Jan 24;15:211-234. doi: 10.1146/annurev-pathmechdis-012419-032611. Epub 2019 Sep 24.
Early developmental conditioning of later health and disease: physiology or pathophysiology?
Hanson MA, Gluckman PD.
Physiol Rev. 2014 Oct;94(4):1027-76. doi: 10.1152/physrev.00029.2013.
[Emerging diseases].
Haug AB.
Tidsskr Nor Laegeforen. 2013 Feb 19;133(4):431; discussion 431. doi: 10.4045/tidsskr.13.0066.
Chronic relapsing eponymy or disease's disease.
Dirckx JH.
Am J Dermatopathol. 1983 Apr;5(2):169-72. doi: 10.1097/00000372-198304000-00016.
Plakophilins and their roles in diseased states.
Hofmann I.
Cell Tissue Res. 2020 Jan;379(1):5-12. doi: 10.1007/s00441-019-03153-0.
Lipidomics in translational research and the clinical significance of lipid-based biomarkers.
Stephenson DJ, Hoeferlin LA, Chalfant CE.
Transl Res. 2017 Nov;189:13-29. doi: 10.1016/j.trsl.2017.06.006. Epub 2017 Jun 15.
Aberrant expression of microRNA-4443 (miR-4443) in human diseases.
Mao Y, Shen J, Wu Y, Wenjing R, Zhu F, Duan S.
Bioengineered. 2022 Jun;13(6):14770-14779. doi: 10.1080/21655979.2022.2109807.
Causal Inference Methods to Integrate Omics and Complex Traits.
Porcu E, Sjaarda J, Lepik K, Carmeli C, Darrous L, Sulc J, Mounier N, Kutalik Z.
Cold Spring Harb Perspect Med. 2021 May 3;11(5):a040493. doi: 10.1101/cshperspect.a040493.
Lessons Learned From Past Gene-Environment Interaction Successes.
Ritz BR, Chatterjee N, Garcia-Closas M, Gauderman WJ, Pierce BL, Kraft P, Tanner CM, Mechanic LE, McAllister K.
Am J Epidemiol. 2017 Oct 1;186(7):778-786. doi: 10.1093/aje/kwx230.
